Skip to main content
. 2011 Mar 21;6(3):e17861. doi: 10.1371/journal.pone.0017861

Table 3. Estimation of invasive potential of Group B streptococcus (GBS) serotypes in different countries.

Serotype Country
South Africa Portugal [34] Israel [36] Sweden [31] Netherlands [37] Taiwan [37]
Ia 163a/31b(0.49; 0.31–0.77)c 42/13(1.52; 0.63–3.67) 12/10(1.14; 0.41–3.18) 15/20(1.37; 0.61–3.10) 24/6(0.52; 0.63–3.67) 13/5(0.22; 0.07–0.70)
Ib 36/7(0.50; 0.22–1.18) 14/1(0.35; 0.04–2.93) 9/2(0.30; 0.05–1.57) 15/2(0.14 0.03–0.64) ND 5/2(0.22; 0.04–1.27)
II 61/7(0.30 0.13–0.67) 46/8(0.85; 0.32–2.27) 23/14(0.83; 0.34–2.03) 13/4(0.32; 0.09–1.07) ND ND
III 202/78(1.00) 59/12(1.00) 26/191.00 36/35(1.00) 20/33(1.00) 19/34(1.00)
IV (20/5)(0.65; 0.23–1.79) 6/1(0.81; 0.09–7.44) ND 3/2(0.69; 0.11–4.36) ND ND
V 55/8(0.38; 0.17–0.83) 59/7(0.58; 0.21–1.59) 18/9(0.68; 0.25–1.85) 25/7(0.29; 0.11–0.75) 14/4(0.17; 0.05–0.60) 15/2(0.07; 0.02–0.36)

In our data two isolates of the same serotype (i.e III) were obtained from the same infant, and only one isolate was included in the analysis.

a

Value indicates colonizing isolates.

b

Value indicates neonatal invasive isolates.

c

Value in parenthesis indicates OR and 95% CI.

d

ND: No data for either invasive, colonization or both isolates.